We are proud to announce that ACARE has partnered with ITACA, the Italian Network for Hereditary and Acquired Angioedema. ACARE and ITACA share common interests, and members of both networks are expert centers for all forms of angioedema and can diagnose, certify and treat HAE as well as angioedema due to acquired C1INH-deficency, contact system activation and mast cell degranulation.
ACARE and ITACA centers employ a multidisciplinary approach and are able to address any clinical needs in pediatric and adult populations. From now on, ITACA will guide their member centers in becoming ACAREs and audits will be conducted jointly (with final approval by the ACARE Steering Committee).
We are looking forward to this undoubtedly fruitful collaboration and to gaining many new ACARE centers in Italy.
Read more news from ACARE
- February 23, 2023
In the hereditary disease hereditary angioedema (HAE), swellings occur in one or more parts of the body without a recognisable trigger. Especially if the upper respiratory tract is affected, a [...]
- October 13, 2023
Dr Thomas Buttgereit is joined by Dr Carolina Vera to discuss the use of attenuated androgens in the treatment of hereditary angioedema and their associated risks and side effects. Both [...]
- March 28, 2023
STATE OF THE ART MANAGEMENT OF RECURRENT ANGIOEDEMA AND HANDS ON TRAINING with special focus on Canada and Europe (applied for CME) Click here to register. The overall aim [...]
